Citations

Clear

3314 citation(s) found for "Do, Alexander".

High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance
Skálová, Alena , Simpson, Roderick H.W., Poorten, Vincent Vander , Willems, Stefan M. , Olsen, Kerry D., Ferlito, Alfio , Vander Poorten, Vincent , Leivo, Ilmo V.V. , Hellquist, Henrik B. , Agaimy, Abbas , Stenman, Göran , Bishop, Justin A. , Franchi, Alessandro , Hernandez‐Prera, Juan C. , Slouka, David

Mayo Clinic

Advances in Anatomic Pathology | March 24, 2021 | Volume: 28 | Issue: 3 | Pages: 107-118

10.1097/pap.0000000000000298 | PMID 33825717 Get It

High-grade transformation (HGT) or dedifferentiation has been described in a variety of salivary gland carcinomas, including acinic cell carcinoma, secretory carcinoma, adenoid cystic carcinoma, epithelial-myoepithelial carcinoma, polymorphous adenocarcinoma, low-grade mucoepidermoid carcinoma, and hyalinizing clear cell carcinoma. High-grade (HG) transformed tumors are composed of a conventional low-grade component characterized by specific microscopic and immunohistochemical features for the given entity, intermingled with or juxtaposed to areas of HG morphology. This is usually either poorly differentiated adenocarcinoma, carcinoma not otherwise specified, or undifferentiated carcinoma, in which the original line of differentiation is lost. The HG component is composed of solid nests of anaplastic cells with large vesicular pleomorphic nuclei, prominent nucleoli, and abundant cytoplasm. Frequent mitoses and extensive necrosis may be present. The Ki-67 labeling index is consistently higher in the HG component. The molecular genetic mechanisms responsible for HGT of salivary gland carcinomas are largely unknown, though p53 inactivation and human epidermal growth factor receptor 2 overexpression and/or gene amplification have been demonstrated in the HG component in a few examples, the frequency varies for each histologic type. Salivary gland carcinomas with HGT are more aggressive than conventional carcinomas, with a higher local recurrence rate and a poorer prognosis. They have a high propensity for cervical lymph node metastasis suggesting a need for a wider resection and neck dissection. HGT of salivary gland carcinoma can occur either at initial presentation or less commonly at the time of recurrence, sometimes following postoperative radiotherapy. The potential for HGT in almost any type of salivary gland carcinoma warrants a thorough sampling of all salivary gland malignancies to prevent oversight of a HG component.
Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries
Russotto, Vincenzo , Laffey, John G. , Tassistro, Elena , Camporota, Luigi , Higgs, A. , Putensen, Christian , Agvald‐Öhman, Christina, Bokums, Kristaps, Brewster, David , Rossi, Emanuela , Fumagalli, Roberto , Pesenti, Antonio, Investigators, INTUBE Study, Ahmed, Hazem , Adhikari, Neill K. J. , Agrawal, Kehari, Agrawal, Nipun , Aguirre-Bermeo, Hernán , Agvald-Öhman, Christina, Ahmad, Meraj, Ajami, Samareh, Akhtar, Shazia N., Alghamdi, Adnan, Alhadi, Abdulmueti , Ali, Syed Muhammad Adnan , Ali, Mohd N., Alias, Anita, Alonso, Julio, Montenegro, Diana Alvarez, Aman, Rubina, Anstey, Matthew , Αrnaoutoglou, Eleni , Baccari, Laura, Baliga, Nishanth, Manjunath, Ramya Ballekatte, Bamane, Shrirang, Bandert, Anna , Bartholdy, Roland, Baturova, Vera , Bellissima, Agrippino , Belsky, Vladislav, Bendre, Prashant, Benini, Annalisa, Besset, Sébastien , Bhattacharyya, Mahuya , Bielański, Piotr, Bigatello, Luca M., Boissier, Florence , Bonney, Iwona, Bowen, David , Boyer, Alexandre, Broman, Lina , Bruel, Cédric , Brunin, Yannick, Bugedo, Guillermo , Calamai, Italo , Campos, Patricia , Canavosio, Federico Giovanni , Cascella, Marco , Catorze, Nuno , Champigneulle, Benoît , Chandwani, Juhi, Chaurasia, Satish, Chawla, Rajesh , Chawla, Aakanksha, Cheetham, Olivia, Chemouni, Frank , Kiok, Lee Chew, Chimunda, Timothy , Chiu, Ching‐Tang , Chiumiento, Fernando, Chudeau, Nicolas , Colica, Sandra, Colin, Gwenhaël , Constantin, Jean‐Michel , Contou, Damien , Costa, Paulo F., Costa, Vasco , Cracchiolo, Andrea, Crone, Petra, Cunha, Rui Pedro, Radivojević, Renata Curić , Dash, Sampat, Pascale, Gennaro De , Torre, Valentina Della, Caprio, Barbara Di, Dimitropoulou, Aikaterini, Edmunds, Christopher , El-Fellah, Nadia, Elhadi, Ahmed , Escudero-Acha, P. , Espinoza, Missael, Esposito, Clelia, Fabretti, Fabrizio, Fein, Daniel , Ferluga, Massimo, Ferré, Alexis , Ferrier, Janet, Flaksa, Marek, Flores, Fernando , Gonzalez, Jesus Flores, Fuentes, Xavier Fonseca , Francis, Roland C. E. , Franco, Daniela G., Franczyk, Pawel, Furman, Mikhail, Gałkin, Piotr, Aguilera, Maria F. García, Garofalo, Eugenio , Gatward, Jonathan, Ghula, Mohamed , Giacomucci, Angelo , Giovannini, Ilaria , Gnanadurai, Kingsly Robert, Godet, Thomas, Fernandez, Gemma Goma , González, María del Carmen Martín, González, Daira, Gopalakrishna, Kadarapura Nanjundaiah , Gottesman, Eric , Gros, Alexandre, Gupta, Manish , Gupta, Kulbhusahn, Hamid, Tarikul , Hamzaoui, Olfa, Hannesdottir, Katrin, Hasan, Shahnaz, Hossain, Mozaffer, Hossein, Sazzad, Hraiech, Sami , Hypes, Cameron, Alkhumsi, Soad Imhmed R., Islam, Motiul, Ismail, Muhamad A., Ivančan, Višnja , Jacquier, Sophie , Jagiasi, Bharat, Jain, Nikhilesh , Jamaluddin, Muhamad Fadhil Hadi, Jeswani, Deepak , Jeswani, Deepti, Jha, Simant , Jones, Benjamin , Jozwiak, Mathieu , Jumić, Aleksandra, Kamp, Oliver , Karametos, Ilias, Karelov, Alexey, Kaufman, David A. , Kaushik, Shuchi, Kesavarapu, Subba R., Khaled, Ala , Khalidah, Hapiz, Khunteta, Sudhir , Kindgen‐Milles, Detlef , Korula, Sara , Kothekar, Amol , Koul, Salman S., Krog, Ditte, Kuellmar, Mira, Kuragayala, Swarna Deepak , Kyparissi, Aikaterini, Labarca, Gonzalo , Lalwani, Jaya, Landaverde, Antonio, Lehr, Andrew , Leonor, Tiago, Licciardi, A, Nava, Claudia L. Lopez, Gallardo, Luis R. Loza, Lungu, Ramona , Luzi, Annalisa, Ma, Wuhua , Μakris, Alexandros , Maheshwarappa, Harish Mallapura , Maraffi, Tommaso , Marcelli, Maria Elena, Mariano, Karim, Marin, Nathalie, Martin, Maëlle, Gonzalez, Mayra Martinez, Matas, Marijana , Matos, Dubier, Maugeri, Jessica Giuseppina , Mazlan, Mohd Zulfakar , Meersch, Melanie , Meher, Ranjan, Mehesry, Tasneem H., Meirik, Maria, Dessap, Armand Mekontso , Mensah, Kwabena , Mercier, Emmanuelle, Midya, Abhirup, Mihaljević, Slobodan , Mirouse, Adrien , Mishra, Prasanna K. , Mistry, Ravi , Moguš, Mate, Nordin, Norbaniza Mohd, Samat, Noryani Mohd, Montini, Luca, Moro, Valeria, Tutillo, Diego Morocho , Mrinal, Sircar, Mudyna, Wojciech, Munta, Kartik, Munusamy, Satheesh , Musso, Stefania, Muttini, Stefano , Irtiza, Ismail Nahla, Nakou, Evi, Narkhede, Amit , Nates, Joseph, Nespoli, M, Nespoli, Francesca, Nikitenko, Artem, Nogueira, Carla, O'Grady, Ross, Odeyemi, Yewande , Ohlsson, Annika , Orsello, Alberto, Palaniswamy, Vijayanand , Palma, Daniela Maria , Palmese, Salvatore , Leal, Jesus N. Pantoja, Papandreou, E., Papanikolaou, Metaxia, Patel, Mayur , Pavlek, Mario , Pedrotti, Niccolò , Hwa, Ngu Pei, Pelagalli, Lorella, Ruiz, Miryam Pérez, Persson, Elin, Petsiou, Athanasia, Philippard, Francois, Piegat, Mariusz, Pili‐Floury, Sébastien, Pinto, Márcia , Piton, Gaël , Plantefève, Gaëtan , Pouplet, Caroline, Pouriki, Sofia, Pradella, Andrea , Prashant, Kumar , Quayle, Alice, Rahmani, Lua S. , Randall, Ian , Ray, Banambar , Reza, Syed T., Ricard, Jean Damien, Riva, Ivano, Rona, Roberto , Rosell, Jon, Rowley, Rebecca, Rumschuessel, Kay, Rundo, Annalisa, Russo, Pierpaolo, Sahu, Samir, Salmon-Gandonnière, Charlotte, Roman, Nandyelly San Juan, Sandefur, Benjamin J. , Santoro, Lida, Sanyal, Rhik, Saravanabavan, Lakshmikanthcharan , Shah, Bhagyesh, Shah, Mehul , Shin, Ming-Hann, Simpson, Shannon, Sinah, Ayush, Singh, D. K., Singh, Nitesh , Singh, Lalit, Skowronski, Lukasz , Sosa, Miguel A. Gama , Spadaro, Savino , Spångfors, Martin , Sperber, Jesper , Spina, Rosario, Srivastava, Anand , Steel, Andrew, Suárez-de-la-Rica, Alejandro , Kumar, Singh Sujeet, Sundrani, Omprakash, Sunil, Nilu, Suparna, Bharadwaj, Surath, Manimala R., Syed, Yadullah, Sztrymf, Benjamin , Tarantino, Stefano, Tileli, Maria, Castro, Hugo Arturo Tirapé , Toledo-Salinas, Otoniel , Tramarin, Jacopo, Tsiftsis, D , Tucić, Iva , León, Jose A. Tutillo, Tutino, Lorenzo, Tyagi, Vijay, Vagdatli, Kyriaki, Varkey, Sneha, Vera, Magdalena , Seth, Magnus Von, Wahlström, C.-G., Ismail, Wan Nasrudin Wan, Winiszewski, Hadrien , Wu, Lun , Zani, Gianluca , Zarka, Jonathan , Zhao, Dawn, Zlotnik, Diane , Bauer, Philippe, Laffey, John G , Labarca, Gonzalo , Alhadi, Abdulmueti , Myatra, Sheila Nainan , Antolini, Laura , Bauer, Philippe R. , Lascarrou, Jean-Baptiste , Szuldrzynski, Konstanty S. , Pelosi, Paolo , Sorbello, Massimiliano , Greif, Robert , Chalkias, Athanasios F. , Pesenti, Antonio, Foti, Giuseppe , Bellani, Giacomo , Investigators, INTUBE Study, Agvald-Öhman, Christina, Ahmad, Meraj, Almekhlafi, Ghaleb A. , Aragão, Irene , Azoulay, Élie , Basto, Marta Lima , Besset, Sebastien, Boni, Elisa, Brazzi, Luca , Broman, Lina, Browne, Alexander, Cappellini, Iacopo , Chao, Anne , Chien, Jung‐Yien , Chou, Nai‐Kuan , Cortegiani, Andrea , Costamagna, Andrea , Cotoia, Antonella , Cracchiolo, Andrea N., Das, Amit, Rosa, Silvia De , Sorbo, Lorenzo Del , Fenza, Raffaele Di , Giacinto, Ida Di , Dudda, Marcel , Ehrentraut, Stefan , Elhadi, Muhammed , Fernandes, Marco, Flores, Fernando, Frat, Jean-Pierre , Fusari, Maurizio , Moraes, Alice Gallo de , Gammaldi, Renato , Gaszynski, Tomasz M , Godet, Thomas , Goffi, Alberto , González-Castro, A. , Guervilly, Christophe , Guitton, Christophe , Huang, Chun‐Kai , Jankowski, Miłosz , Jones, Laura, Karelov, Alexey, Katsoulis, P. , Kaye, Callum T. , Khalidah, Hapiz, Khan, Akram , Ku, Shih‐Chi , Kuo, Lu-Cheng , Lalwani, Jaya, Laserna, Andrés , Lee, Chien‐Chang , Legriel, Stéphane , Li, Yongxing , Licciardi, Anna Lisa, Litton, Edward , Ломиворотов, В. В. , Longhini, Federico , Магомедов, М. А. , Геннадьевна, Марова Надежда , Maseda, Emilio , Mastroianni, Fiore , Michálek, Pavel , Mishra, Prasanna, Mistry, Ravi, Montini, Luca , Montrucchio, Giorgia Giuseppina , Mosier, Jarrod , Mudyna, Wojciech, Müller, Grégoire , Munta, Kartik, Musso, Stefania, Nakou, Evi, Nates, Joseph L. , Nogueira, Carla, Leal, Jesús Nicolás Pantoja, Papandreou, Eleni, Parotto, Matteo , Persson, Elin, Pezzi, Angelo , Philip, Sam, Pinciroli, Riccardo , Pinto, Marcia, Pouplet, Caroline, Regli, Adrian , Roca, Oriol , Rosell, Jon, Ruan, Sheng‐Yuan , Sahu, Samir, Sales, Gabriele , Roman, Nandyelly San Juan, Sánchez‐Hurtado, Luis Alejandro , Santafe, Manel, Sanyal, Rhik, Shah, Bhagyesh, Silva, Monica, Simpson, Shannon, Singh, Atul Kumar , Singh, Lalit, Sosa, Miguel A., Srivastava, Anand, Szakmány, Tamás , Tabah, Alexis , León, José Andrés Tutillo , Wahlstrom, Carl, Hassan, Wan Mohd Nazaruddin Wan , Wang, Kuo‐Chuan , Wu, Jiayan , Yeh, Yu‐Chang , Young, Paul J.

Mayo Clinic

JAMA | March 23, 2021 | Volume: 325 | Issue: 12 | Pages: 1164

10.1001/jama.2021.1727 | PMID 33755076 Get It

Renal function outcomes and kidney biopsy features of living kidney donors with hypertension
Merzkani, Massini , Đenić, Aleksandar , D’Costa, Matthew R. , Iverson, Ryan, Kremers, Walter K. , Alexander, Mariam P., Textor, Stephen C., Taler, Sandra J. , Stegall, Mark D. , Augustine, Joshua J. , Issa, Naim , Merzkani, Massini A , Mullan, Aidan, D'Costa, Matthew , Stegall, Mark D , Issa, Naim , Denic, Aleksandar , Kremers, Walter K , Mullan, Aidan F. , Iverson, Ryan, Augustine, Joshua , Rule, Andrew D.

Mayo Clinic

Clinical Transplantation | March 21, 2021 | Volume: 35 | Issue: 6 | Pages: No page available

10.1111/ctr.14293 | PMID 33745214 Get It

AbstractBackgroundThe medium‐ to long‐term outcomes of living kidney donors with hypertension compared to normotensive donors are not well understood, especially with the recent changes in hypertension guidelines.MethodsWe studied a cohort of 950 living kidney donors using different definitions of hypertension based on either ≥140/90 or ≥130/80 mmHg thresholds and based on either office or ambulatory blood pressure readings. Microstructural features on kidney biopsy at the time of donation were compared using different definitions of hypertension.ResultsAfter adjusting for years of follow‐up, age, sex, and baseline eGFR, hypertension (by any definition) did not significantly predict an eGFR < 45 ml/min/1.73 m2 at a median follow‐up of 10 years postdonation, though there was a borderline association with ambulatory blood pressure ≥ 130/80 mmHg predicting a 40% decline in eGFR (OR = 1.53, 1.00–2.36; p = .051). Proteinuria was predicted by office blood pressure ≥ 140/90 mmHg and by nondipper profile on nocturnal ambulatory blood pressure measurements. At the time of donation, larger glomeruli and arterial hyalinosis on biopsy were associated with hypertension defined by either ≥140/90 or ≥130/80 mmHg (by office or ambulatory measurements). Nocturnal nondipper status was associated with larger glomeruli size but not arteriolar hyalinosis when compared to dippers.ConclusionsIn programs that accept donors with controlled hypertension, various definitions of hypertension are associated with histological findings in the donated kidney, but none predict a clinically significant decline in kidney function 10 years after donation. These data support allowing healthy individuals with controlled hypertension to donate a kidney. However, donors with office hypertension (≥140/90 mmHg) and nondippers (regardless of hypertension status) are at greater long‐term risk for proteinuria, and particularly for these donors, longer follow‐up is warranted.
Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
Pol, Tymon , Lindbäck, Johan , Alexander, John H. , Caterina, Raffaele De , Eikelboom, JW, Ezekowitz, Michael D. , Granger, Christopher B. , Siegbahn, Agneta , Wallentin, Lars , Lindbäck, Johan , De Caterina, Raffaele , Granger, Christopher B , Hijazi, Ziad , Bahit, Maria Cecilia , Eikelboom, John W. , Gersh, Bernard J. , Hylek, Elaine M. , Lópes, Renato D.

Mayo Clinic

Open Heart | March 19, 2021 | Volume: 8 | Issue: 1 | Pages: e001471

10.1136/openhrt-2020-001471 | PMID 33741689 Get It

Objectives Growth differentiation factor 15 (GDF-15) is a biomarker independently associated with bleeding and death in anticoagulated patients with atrial fibrillation (AF). GDF-15 is also used as one component in the more precise biomarker-based ABC (age, biomarkers, clinical history)-AF-bleeding and ABC-AF-death risk scores. Data from large trials indicate a geographic variability in regard to overall outcomes, including bleeding and mortality risk. Our aim was to assess the consistency of the association between GDF-15, ABC-AF-bleeding score and ABC-AF-death score, with major bleeding and death, across world geographic regions. Methods Data were available from 14 767 patients with AF from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial and 8651 patients with AF from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial in this cohort study. GDF-15 was analysed from plasma samples obtained at randomisation. The geographical consistency of the associations between outcomes and GDF-15, ABC-AF-bleeding score and ABC-AF-death scores were assessed by Cox-regression models including interactions with predefined geographical region. Results GDF-15 and the ABC-AF-bleeding score were associated with major bleeding in both trials across regions (p<0.0001). Similarly, GDF-15 and the ABC-AF-death score were associated with all-cause mortality in both trials across regions (p<0.0001). Overall, the association between GDF-15, the ABC-AF-bleeding score and ABC-AF-death risk score with major bleeding and death was consistent across regions in both ARISTOTLE and the RE-LY trial cohorts. The ABC-AF-bleeding and ABC-AF-death risk scores were consistent regarding discriminative ability when comparing geographic regions in both trial cohorts. The C-indices ranged from 0.649 to 0.760 for the ABC-AF-bleeding and from 0.677 to 0.806 for the ABC-AF-death score by different geographic regions. Conclusions In patients with AF on anticoagulation, GDF-15 and the biomarker-based ABC-AF-bleeding and ABC-AF-death risk scores are consistently associated with respectively increased risk of major bleeding and death and have similar prognostic value across world geographic regions. Trial registration number ClinicalTrials.gov Registry NCT00412984 and NCT00262600.
Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after TREAT trial showed they are ineffective and unsafe
Vu, Khoa , Zhou, Jiani , Everhart, Alexander , Jena, Anupam B. , Karaca‐Mandic, Pinar , Desai, Nihar R. , Herrin, Jeph , Ross, Joseph S. , Shah, Nilay

Mayo Clinic

No container title available | March 18, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-329817/v1 Get It

Abstract Variation in de-adoption of ineffective or unsafe treatments is not well-understood. We examined de-adoption of erythropoiesis-stimulating agents (ESA) in anemia treatment among patients with chronic kidney diseases (CKD) following new clinical evidence of harm and ineffectiveness (the TREAT trial) and the FDA's revision of its safety warning. We used an interrupted time series approach to estimate changes in use of epoetin alfa (EPO) and darbepoetin alfa (DPO) in the commercial and Medicare Advantage (MA) and Medicare fee-for-service (FFS) populations. We also examined how changes in both trends and levels of use were associated with physicians’ characteristics. Study cohort included patients with CKD stages 3 to 5 during 2007-2015. Use of DPO and EPO declined over the study period. There were no consistent changes in DPO trend across insurance groups, but the level of DPO use decreased right after the FDA revision in all groups. The decline in EPO use trend was faster after the TREAT trial for all groups. Nephrologists were largely more responsive to evidence than primary care physicians. Differences by physician's gender, and age were not consistent across insurance populations and types of ESA.
Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Rheenen, Wouter van , Spek, Rick van der, Berg, Leonard van den, Hop, Paul , Zwamborn, Ramona, Klein, Niek de , Westra, Harm-Jan , Bakker, Olivier, Shireby, Gemma , Dolzhenko, Egor, Dekker, Annelot, Westeneng, Henk-Jan, Tazelaar, Gijs, Eijk, Kristel van , Kooyman, Maarten , Doherty, Mark, Iacoangeli, Alfredo, Cooper‐Knock, Johnathan , Smith, Bradley , Chandran, Siddharthan , Morrison, Karen, Shaw, Pamela, Hardy, John , Orrell, Richard, Basak, Nazli, Ratti, Antonia, Pinter, Guiseppe Lauria, D'Alfonso, Sandra, Soraru, Gianni, Padovani, Alessandro , Moglia, Cristina, Brunetti, Maura, Canosa, Antonio, Grassano, Maurizio, Nefussy, Beatrice, Nordin, Angelica, Lerner, Yossef, Zabari, Michal, Baloh, Robert, Bell, Shaugn, Vourc'h, Patrick, Corcia, Philippe, Couratier, Philippe, Meininger, Vincent, Salachas, Francois, Pardina, Jesús Mora, Assialioui, Abdelilah , Rojas‐García, Ricardo , Dion, Patrick, Ludolph, Albert, Weishaupt, Jochen, Brenner, David, Freischmidt, Axel , Bensimon, Gilbert , Durr, Alexandra, Payan, Christine, Saker-Delye, Safa, Wood, Nicholas , Rademakers, Rosa, Tittmann, Lukas, Lieb, Wolfgang, Braun, Alice, Hofman, Albert, Cichon, Sven , Traynor, Bryan, Singleton, Andrew, Neto, Miguel Mitne, Ophoff, Roel, Wiedau-Pazos, Martina, Lomen-Hoerth, Catherine, Rödiger, Annekathrin, Jörk, Alexander, Barthel, Tabea, Theele, Erik, Ilse, Berjamin, Stubendorff, Beatrice, Witte, Otto W. , Hübner, Christian, Graff, Caroline , Brylev, Lev, Fominykh, Vera, Demeshonok, Vera, Ataulina, Anastasia , Koritnik, Blaž , Zidar, Janez , Ravnik-Glavač, Metka, Glavač, Damjan, Stević, Zorica, Drory, Vivian, Povedano, Mónica, Henderson, Robert , Furlong, Sarah , McCombe, Pamela, Ngo, Shyuan, Steyn, Frederik, Mather, Karen A. , Sachdev, Perminder S. , Henders, Anjali, Carvalho, Mamede de, Petri, Susanne, Weber, Markus , Glass, Jonathan D. , Brown, Robert, Landers, John, Garton, Fleur, McRae, Allan, Mill, Jonathan , Kenna, Kevin, Runz, Heiko, Franke, Lude , Damme, Philip Van , Gaur, Nayana , Steyn, Frederik J. , Landers, John E. , Westra, Harm-Jan , Steyn, F J , Cichon, Sven , Sachdev, Perminder S , Van Damme, Philip , Hardy, John , Padovani, Alessandro , Graff, Caroline , Spek, Rick A. A. van der , Bakker, Mark K. , Veldink, Jan H. , Vugt, Joke J.F.A. van , Zwamborn, Ramona A.J. , Deelen, Patrick , Hannon, Eilís , Moisse, Matthieu , Baird, Denis A. , Restuadi, Restuadi , Gawor, Klara , Westeneng, Henk‐Jan , Byrne, Ross Patrick , Heverin, Mark , Khleifat, Ahmad Al , Iacoangeli, Alfredo , Shatunov, Aleksey , Ticozzi, Nicola , Gromicho, Marta , Pal, Suvankar , Orrell, Richard W., Sendtner, Michael , Meyer, Thomas , Basak, Nazli A., Kooi, Anneke J. van der , Ratti, Antonia , Fogh, Isabella , Gellera, Cinzia , Corti, Stefania Paola , Cereda, Cristina , Sproviero, Daisy , D’Alfonso, Sandra , Siciliano, Gabriele , Filosto, Massimiliano , Chiò, Adriano , Calvo, Andrea , Moglia, Cristina , Brunetti, Maura , Canosa, Antonio , Grassano, Maurizio , Beghi, Ettore , Pupillo, Elisabetta , Logroscino, Giancarlo , Osmanovic, Alma , Nordin, Angelica , Lerner, Yossef, Zabari, Michal, Gotkine, Marc , Vourc’h, Patrick , Corcia, Philippe , Couratier, Philippe , Millecamps, Stéphanie , Meininger, Vincent, Salachas, François, Ross, Jay P. , Ludolph, Albert, Brice, Alexis , Dürr, Alexandra , Saker-Delye, Safaa, Wood, Nicholas , Topp, Simon , Rademakers, Rosa , Tittmann, Lukas , Franke, André , Ripke, Stephan , Braun, Alice , Kraft, Julia , Whiteman, David C. , Olsen, Catherine M. , Uitterlinden, André G. , Hofman, Albert, Rietschel, Marcella , Nöthen, Markus M. , Amouyel, Philippe , Traynor, Bryan J. , Singleton, Andrew, Cauchi, Ruben J. , Ophoff, Roel A. , Lomen‐Hoerth, Catherine , Deerlin, Vivianna M. Van , Großkreutz, Julian , Rödiger, Annekathrin, Jörk, Alexander, Barthel, Tabea, Theele, Erik, Steinbach, Robert , Hübner, Christian, Fominykh, Vera , Demeshonok, Vera, Rogelj, Boris , Drory, Vivian, Blair, Ian P. , Kiernan, Matthew C. , Benyamin, Beben , Mathers, Susan , Needham, Merrilee , Ngo, Shyuan T. , Nicholson, Garth A. , Pamphlett, Roger , Rowe, Dominic B. , Williams, Kelly L. , Wallace, Leanne M. , Carvalho, Mamede A. de , Pinto, Susana , Petri, Susanne , Rouleau, Guy Armand , Silani, Vincenzo , Curtis, Charles J. C. , Breen, Gerome , Brown, Robert, Shaw, Christopher E. , Andersen, Peter Munch , Groen, Ewout J. N. , Es, Michael A. van , Pasterkamp, R. Jeroen , Fan, Dongsheng , Smith, George Davey , Gaunt, Tom R. , Eberle, Michael A. , McLaughlin, Russell L. , Hardiman, Orla , Wray, Naomi , Tsai, Ellen A. , Runz, Heiko , Al‐Chalabi, Ammar

Mayo Clinic

No container title available | March 18, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-322430/v1 Get It

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a life-time risk of 1 in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry GWAS in ALS including 29,612 ALS patients and 122,656 controls which identified 15 risk loci in ALS. When combined with 8,953 whole-genome sequenced individuals (6,538 ALS patients, 2,415 controls) and the largest cortex-derived eQTL dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, repeat expansions or regulatory effects. ALS associated risk loci were shared with multiple traits within the neurodegenerative spectrum, but with distinct enrichment patterns across brain regions and cell-types. Of the environmental and life-style risk factors obtained from literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. All ALS associated signals combined reveal a role for perturbations in vesicle mediated transport and autophagy, and provide evidence for cell-autonomous disease initiation in glutamatergic neurons.
Hemispherectomy Outcome Prediction Scale: Development and validation of a seizure freedom prediction tool
Weil, Alexander G. , Lewis, Evan , Ibrahim, George M. , Tseng, Chi‐Hong , Zhou, Xinkai , Lin, Kao‐Min, Cai, Lixin , Liu, Qingzhu , Lin, Jiuluan , Mathern, Gary W. , Smyth, Matthew D. , O’Neill, Brent R., Dudley, Roy , Ragheb, John , Bhatia, Sanjiv, Delev, Daniel , Ramantani, Georgia , Zentner, Josef , Dorfer, Christian , Feucht, Martha , Czech, Thomas , Bollo, Robert J. , Issabekov, Galymzhan , Zhu, Hongwei , Connelly, Mary Shane, Steinbok, Paul , Zhang, Kai , Hidalgo, Eveline Teresa , Weiner, Howard L. , Lapalme‐Remis, Samuel , Tripathi, Manjari , Chandra, P. Sarat , Hader, Walter , Wang, Feng‐Peng , Champagne, Pierre Olivier, Budke, Marcelo , Pérez-Jiménez, María Ángeles, Raftapoulos, Christian, Finet, Patrice, Michel, Pauline, Schaller, Karl , Malone, Christian Cantillano, Pociecha, Juan , Chamorro, Noelia, Muro, Valeria L., Lehe, Marec von , Vieker, Silvia, Oluigbo, Chima , Gaillard, William D. , Khateeb, Mashael Al, Alotaibi, Faisal , Krayenbühl, Niklaus , Bolton, Jeffrey , Ramantani, Georgia , Dorfer, Christian , Feucht, Martha , Wong-Kisiel, Lily, Tripathi, Manjari , Sarat Chandra, Poodipedi , Gaillard, William D , Fallah, Aria , von Lehe, Marec , Weil, Alexander G , Oluigbo, Chima O , Kola, Olivia , Zhou, Wen-Jing , Ojemann, Jeffrey G. , Wang, Anthony , Connelly, Mary, Zhang, Jianguo , Wong‐Kisiel, Lily C. , Wang, Feng‐Peng, Yao, Yi , Guo, Qiang , Li, Shao‐Chun, Stienen, Martin Nikolaus , Baro, Valentina , Pearl, Phillip L. , Fallah, Aria

Mayo Clinic

Epilepsia | March 13, 2021 | Volume: 62 | Issue: 5 | Pages: 1064-1073

10.1111/epi.16861 | PMID 33713438 Get It

AbstractObjectiveTo develop and validate a model to predict seizure freedom in children undergoing cerebral hemispheric surgery for the treatment of drug‐resistant epilepsy.MethodsWe analyzed 1267 hemispheric surgeries performed in pediatric participants across 32 centers and 12 countries to identify predictors of seizure freedom at 3 months after surgery. A multivariate logistic regression model was developed based on 70% of the dataset (training set) and validated on 30% of the dataset (validation set). Missing data were handled using multiple imputation techniques.ResultsOverall, 817 of 1237 (66%) hemispheric surgeries led to seizure freedom (median follow‐up = 24 months), and 1050 of 1237 (85%) were seizure‐free at 12 months after surgery. A simple regression model containing age at seizure onset, presence of generalized seizure semiology, presence of contralateral 18‐fluoro‐2‐deoxyglucose–positron emission tomography hypometabolism, etiologic substrate, and previous nonhemispheric resective surgery is predictive of seizure freedom (area under the curve = .72). A Hemispheric Surgery Outcome Prediction Scale (HOPS) score was devised that can be used to predict seizure freedom.SignificanceChildren most likely to benefit from hemispheric surgery can be selected and counseled through the implementation of a scale derived from a multiple regression model. Importantly, children who are unlikely to experience seizure control can be spared from the complications and deficits associated with this surgery. The HOPS score is likely to help physicians in clinical decision‐making.
Prognostic Impact of Acute Pulmonary Triggers in Patients with Takotsubo Syndrome: New Insights from the International Takotsubo Registry
Cammann, Victoria L. , Napp, L. Christian , Szawan, Konrad A. , Micek, Jozef, Dreiding, Sara, Levinson, Rena A. , Petkova, Vanya, Würdinger, Michael , Sumalinog, Rafael, Gili, Sebastiano , Clarenbach, Christian F. , Kohler, Malcolm , Wischnewsky, Manfred , Citro, Rodolfo , Vecchione, Carmine , Bossone, Eduardo , Franke, Jennifer , Meder, Benjamin , Knorr, Maike, Heiner, Susanne, Burgdorf, Christof , Kherad, Behrouz , Tschöpe, Carsten , Sarcon, Annahita, Shinbane, Jerold S., Rajan, Lawrence, Michels, Guido, Pfister, Roman , Cuneo, Alessandro , Jacobshagen, Claudius, Karakas, Mahir , Köenig, Wolfgang , Pott, Alexander , Meyer, Philippe , Roffi, Marco , Banning, Adrian , Wolfrum, Mathias , Cuculi, Florim , Fischer, Thomas, Vasankari, Tuija , Budnik, Monika , Dworakowski, Rafał , MacCarthy, Philip , Osswald, Stefan , Galiuto, Leonarda , Chan, Christina , Bridgman, Paul , Beug, Daniel , Gilyarova, Ekaterina, Gilyarov, Mikhail , El‐Battrawy, Ibrahim , Akın, İbrahim , Kozel, Martin , Winchester, David E. , Ukena, Christian , Carrilho‐Ferreira, Pedro , Hauck, Christian , Paolini, Carla , Bilato, Claudio , Sano, Masanori, Ishibashi, Iwao, Takahara, Masayuki, Himi, Toshiharu, Kobayashi, Yoshio , Prasad, Abhiram , Rihal, Charanjit S. , Liu, Kan , Bianco, Matteo , Jörg, Lucas, Rickli, Hans , Pestana, Gonçalo , Böhm, Michael , Maier, Lars S. , Pinto, Fausto J. , Widimský, Petr , Felix, Stephan B. , Opolski, Grzegorz , Rottbauer, Wolfgang , Pieske, Burkert , Borggrefe, Martin, Katus, Hugo A. , Münzel, Thomas , Crea, Filippo , Lüscher, Thomas F. , Ghadri, Jelena R. , Templin, Christian , Gilyarov, Mikhail , Bossone, Eduardo , Crea, Filippo , Citro, Rodolfo , El-Battrawy, Ibrahim , Prasad, Abhiram , Vecchione, Carmine , Tschöpe, Carsten , Koenig, Wolfgang , Meyer, Philippe , Banning, Adrian , Gilyarov, Mikhail , Ukena, Christian , Bilato, Claudio , Bianco, Matteo , Kato, Ken , Patrascu, Alexandru , Neuhaus, Michael, Jaguszewski, Miłosz , Noutsias, Michel , D’Ascenzo, Fabrizio , Dichtl, Wolfgang , Kobza, Richard , Airaksinen, Juhani , Kaiser, Christoph A. , Delmas, Clément , Lairez, Olivier , Shilova, Alexandra S. , Toušek, Petr , Gałuszka, Jan , Poglajen, Gregor , Rihal, Charanjit S. , Schulze, Paul Christian , Nguyen, Thanh Ha Tuan , Braun-Dullaeus, Ruediger Christian , Hasenfuß, Gerd , Schunkert, Heribert , Thiele, Hölger , Bauersachs, Johann , Horowitz, John D. , Mario, Carlo Di , Bax, Jeroen J. , Ruschitzka, Frank T.

Mayo Clinic

ESC Heart Failure | March 13, 2021 | Volume: 8 | Issue: 3 | Pages: 1924-1932

10.1002/ehf2.13165 | PMID 33713566 Get It

Abstract Aims Acute pulmonary disorders are known physical triggers of takotsubo syndrome (TTS). This study aimed to investigate prevalence of acute pulmonary triggers in patients with TTS and their impact on outcomes. Methods and results Patients with TTS were enrolled from the International Takotsubo Registry and screened for triggering factors and comorbidities. Patients were categorized into three groups (acute pulmonary trigger, chronic lung disease, and no lung disease) to compare clinical characteristics and outcomes. Of the 1670 included patients with TTS, 123 (7%) were identified with an acute pulmonary trigger, and 194 (12%) had a known history of chronic lung disease. The incidence of cardiogenic shock was highest in patients with an acute pulmonary trigger compared with those with chronic lung disease or without lung disease (17% vs. 10% vs. 9%, P = 0.017). In-hospital mortality was also higher in patients with an acute pulmonary trigger than in the other two groups, although not significantly (5.7% vs. 1.5% vs. 4.2%, P = 0.13). Survival analysis demonstrated that patients with an acute pulmonary trigger had the worst long-term outcome (P = 0.002). The presence of an acute pulmonary trigger was independently associated with worse long-term mortality (hazard ratio 2.12, 95% confidence interval 1.33–3.38; P = 0.002). Conclusions The present study demonstrates that TTS is related to acute pulmonary triggers in 7% of all TTS patients, which accounts for 21% of patients with physical triggers. The presence of acute pulmonary trigger is associated with a severe in-hospital course and a worse long-term outcome.
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Bergan, Stein , Hesselink, Dennis A. , Johnson‐Davis, Kamisha L. , Kunicki, Paweł K. , Lemaı̂tre, F. , Marquet, Pierre , Molinaro, Mariadelfina , Noceti, Ofelia , Pattanaik, Smita , Seger, Christoph , Shipkova, Maria , Swen, Jesse J. , Gelder, Teun van , Venkataramanan, Raman , Wieland, Eberhard , Woillard, Jean‐Baptiste , Zwart, Tom C. , Barten, M.J., Budde, Klemens , Haufroid, Vincent , Millán, Olga , Mizuno, Tomoyuki , Oellerich, Michael , Salzmann, Linda, Tönshoff, Burkhard , Schaik, Ron H. N. van , Vethe, Nils Tore , Vinks, Alexander A. , Wallemacq, Pierre, Åsberg, Anders , Langman, Loralie J., Budde, Klemens , Brunet, Merçè , Pawiński, Tomasz , Dieterlen, Maja‐Theresa , Elens, Laure , Masuda, Satohiro , Moes, Dirk Jan A. R. , Picard, Nicolas

Mayo Clinic

Therapeutic Drug Monitoring | March 12, 2021 | Volume: 43 | Issue: 2 | Pages: 150-200

10.1097/ftd.0000000000000871 | PMID 33711005 Get It

Abstract: When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area under the curve based on the measurement of drug concentrations in only a few samples. This approach is feasible in the clinical routine and has proven successful in terms of correlation with outcome. However, the search for superior correlates has continued, and numerous studies in search of biomarkers that could better predict the perfect dosage for the individual patient have been published. As it was considered timely for an updated and comprehensive presentation of consensus on the status for personalized treatment with MPA, this report was prepared following an initiative from members of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). Topics included are the criteria for analytics, methods to estimate exposure including pharmacometrics, the potential influence of pharmacogenetics, development of biomarkers, and the practical aspects of implementation of target concentration intervention. For selected topics with sufficient evidence, such as the application of limited sampling strategies for MPA area under the curve, graded recommendations on target ranges are presented. To provide a comprehensive review, this report also includes updates on the status of potential biomarkers including those which may be promising but with a low level of evidence. In view of the fact that there are very few new immunosuppressive drugs under development for the transplant field, it is likely that MPA will continue to be prescribed on a large scale in the upcoming years. Discontinuation of therapy due to adverse effects is relatively common, increasing the risk for late rejections, which may contribute to graft loss. Therefore, the continued search for innovative methods to better personalize MPA dosage is warranted.
A large-scale multi-ethnic genome-wide association study of coronary artery disease
Tcheandjieu, Catherine , Zhu, Xiang , Clarke, Shoa L. , Lee, Kyung Min , Chen, Fei , Pyarajan, Saiju , Song, Rebecca J. , Plomondon, Mary E. , Waldo, Stephen W. , Sinnott-Armstrong, Nasa , Wojcik, Genevieve L. , Haessler, Jeffrey, Do, Ron , North, Kari, Haiman, Christopher, Bis, Joshua, Shen, Botong, Lange, Leslie A., Lu, Yingchang , Stanaway, Ian B. , Hebbring, Scott J. , Namjou, Bahram , Kaufman, Kenneth M. , Kamatani, Yoichiro, Ritchie, Marylyn D. , Baras, Aris , Natarajan, Pradeep , Raghavan, Sridharan , Lee, Jennifer , Tang, Hua, Sun, Yan V. , O’Donnell, Christopher J. , Kathiresan, Sekar , Saleheen, Danish , Gaziano, J. Michael , Reaven, Peter D. , Cho, Kelly , Graff, Mariaelisa , Huang, Jie , Clarke, Shoa L , Do, Ron , Natarajan, Pradeep , Min Lee, Kyung , Assimes, Themistocles L. , Hilliard, Austin T. , Napolioni, Valerio , Ma, Shining , Fang, Huaying , Gorman, Bryan R. , Maddox, Thomas M , Ho, Yuk-Lam Anne , Buyske, Steven , Kooperberg, Charles , Loos, Ruth J. F. , Verbanck, Marie , Chaudhary, Kumardeep , Avery, Christy L. , Marchand, Loı̈c Le , Wilkens, Lynne R. , Leonard, Hampton L. , Giri, Ayush , Dikilitas, Ozan , Kullo, Iftikhar J. , Jarvik, Gail P. , Gordon, Adam, Koyama, Satoshi , Ito, Kaoru , Ishigaki, Kazuyoshi , Kamatani, Yoichiro, Tsao, Noah L. , Verma, Shefali S. , Kember, Rachel L. , Lotta, Luca Andrea , Levin, Michael G. , Hauser, Elizabeth R. , Miller, Donald Ray , Vujković, Marijana , Huffman, Jennifer E. , Klarin, Derek , Voight, Benjamin F. , Rader, Daniel J , Chang, Kyong‐Mi , Damrauer, Scott M , Lynch, Julie A. , Wilson, Peter W.F. , Tsao, Philip S. , Bick, Alexander G.

Mayo Clinic

No container title available | March 10, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-275591/v1 Get It

Abstract Coronary artery disease (CAD) is a leading cause of death, yet its genetic determinants are not fully elucidated. We report a multi-ethnic genome-wide association study of CAD involving nearly a quarter of a million cases, incorporating the largest cohorts to date of Whites, Blacks, and Hispanics from the Million Veteran Program with existing studies including CARDIoGRAMplusC4D, UK Biobank, and Biobank Japan. We verify substantial and nearly equivalent heritability of CAD across multiple ancestral groups, discover 107 novel loci including the first nine on the X-chromosome, identify the first eight genome-wide significant loci among Blacks and Hispanics, and demonstrate that two common haplotypes are largely responsible for the risk stratification at the well-known 9p21 locus in most populations except those of African origin where both haplotypes are virtually absent. We identify 15 loci for angiographically derived burden of coronary atherosclerosis, which robustly overlap with the strongest and earliest loci reported to date for clinical CAD. Phenome-wide association analyses of novel loci and externally validated polygenic risk scores (PRS) augment signals from the insulin resistance cluster of risk factors and consequences, extend previously established pleiotropic associations of loci with traditional risk factors to include smoking and family history, and confirm a substantially reduced transferability of existing PRS to Blacks. Downstream integrative genomic analyses reinforce the critical role of endothelial, fibroblast, and smooth muscle cells within the coronary vessel wall in CAD susceptibility. Our study highlights the value of a multi-ethnic design in efficiently characterizing the genetic architecture of CAD across all human populations.